Pirbright Institute, Pirbright, Surrey, United Kingdom.
J Virol. 2013 Aug;87(15):8735-44. doi: 10.1128/JVI.01138-13. Epub 2013 Jun 5.
Field isolates of foot-and-mouth disease virus (FMDV) have a restricted cell tropism which is limited by the need for certain RGD-dependent integrin receptors. In contrast, cell culture-adapted viruses use heparan sulfate (HS) or other unidentified molecules as receptors to initiate infection. Here, we report several novel findings resulting from cell culture adaptation of FMDV. In cell culture, a virus with the capsid of the A/Turkey/2/2006 field isolate gained the ability to infect CHO and HS-deficient CHO cells as a result of a single glutamine (Q)-to-lysine (K) substitution at VP1-110 (VP1-(Q)110(K)). Using site-directed mutagenesis, the introduction of lysine at this same site also resulted in an acquired ability to infect CHO cells by type O and Asia-1 FMDV. However, this ability appeared to require a second positively charged residue at VP1-109. CHO cells express two RGD-binding integrins (α5β1 and αvβ5) that, although not used by FMDV, have the potential to be used as receptors; however, viruses with the VP1-(Q)110(K) substitution did not use these integrins. In contrast, the VP1-(Q)110(K) substitution appeared to result in enhanced interactions with αvβ6, which allowed a virus with KGE in place of the normal RGD integrin-binding motif to use αvβ6 as a receptor. Thus, our results confirmed the existence of nonintegrin, non-HS receptors for FMDV on CHO cells and revealed a novel, non-RGD-dependent use of αvβ6 as a receptor. The introduction of lysine at VP1-110 may allow for cell culture adaptation of FMDV by design, which may prove useful for vaccine manufacture when cell culture adaptation proves intractable.
口蹄疫病毒(FMDV)的田间分离株具有有限的细胞嗜性,这受到某些 RGD 依赖性整联蛋白受体的限制。相比之下,细胞培养适应的病毒使用肝素硫酸酯(HS)或其他未鉴定的分子作为受体来启动感染。在这里,我们报告了 FMDV 细胞培养适应产生的一些新发现。在细胞培养中,一种具有 A/Turkey/2/2006 田间分离株衣壳的病毒由于 VP1-110 处单个谷氨酰胺(Q)到赖氨酸(K)取代(VP1-(Q)110(K)),获得了感染 CHO 和 HS 缺陷型 CHO 细胞的能力。使用定点突变,在相同位置引入赖氨酸也导致 O 型和亚洲-1 型 FMDV 获得感染 CHO 细胞的能力。然而,这种能力似乎需要 VP1-109 处的第二个带正电荷的残基。CHO 细胞表达两种 RGD 结合整联蛋白(α5β1 和 αvβ5),尽管 FMDV 不使用它们,但它们有可能被用作受体;然而,具有 VP1-(Q)110(K)取代的病毒不使用这些整联蛋白。相比之下,VP1-(Q)110(K)取代似乎导致与αvβ6 的相互作用增强,这使得具有 KGE 而不是正常 RGD 整联蛋白结合基序的病毒能够将αvβ6 用作受体。因此,我们的结果证实了 CHO 细胞上 FMDV 的非整联蛋白、非 HS 受体的存在,并揭示了αvβ6 作为受体的新型非 RGD 依赖性用途。VP1-110 处赖氨酸的引入可能允许 FMDV 的细胞培养适应设计,当细胞培养适应变得棘手时,这可能对疫苗制造有用。